Working towards more effective tuberculosis (TB) vaccinations, researchers at Weill Cornell Medicine have developed two ...
In an interview with THE WEEK Dr Swapnil M. Khadake, HOD & Consultant Critical Care, Fortis Hiranandani Hospital talks about ...
3h
News Medical on MSNResearchers create mycobacteria with kill switches to improve TB vaccine safetyWorking toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that can be triggered to stop the ...
Dehradun: A recent report by the Comptroller and Auditor General (CAG) of India, presented during the Uttarakhand assembly ...
Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.
But the relative size of the outbreak is irrelevant. Kansas numbers continue to grow, and Dr. William Schaffner, infectious ...
Of children aged 5 to 10 years, about 40% had abnormal lung function post-treatment, rising to 65% in older children.
A new drug trial is using a vaccine that has been around for more than 100 years, to help people living with type one ...
Now a museum, the Saranac Laboratory was established in 1894 and was the first in the United States dedicated to studying tuberculosis.
STC Puducherry and IGMCRI host marathon to raise TB awareness, emphasizing early diagnosis and treatment for combatting the ...
Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...
Abbye E. Alexander, Christopher J. Tellner, and Henry Norwood of Kaufman Dolowich LLP discuss issues regarding causes of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results